Key result
Conservative management resolves cardiogenic shock in a case of COVID-19-associated Takotsubo cardiomyopathy.
Case Report (n=1)
No
This case highlights that acute COVID-19 pneumonia can be associated with Takotsubo cardiomyopathy presenting as cardiogenic shock, which can resolve completely with supportive medical management.
May support conservative management in select COVID-19 Takotsubo shock cases; hypothesis-generating and requires prospective validation.
Cardiogenic shock carries a high burden of morbidity and mortality because of inadequate tissue perfusion leading to end-stage multi-organ damage. The initial work-up includes a pertinent and thorough history and physical examination to identify possible cardiac and noncardiac etiologies. The following case describes a patient presenting with symptomatic acute COVID-19 (SARS-CoV-2) pneumonia with initial findings consistent with cardiogenic shock. SARS-CoV-2 pneumonia has been associated with multiple cardiac manifestations including myocarditis, heart failure, myocardial infarction, and Takotsubo cardiomyopathy. This patient was treated with conservative medical management and had complete clinical recovery and normal cardiac angiography weeks after their initial presentation. This clinical scenario highlights the significance of a broad differential and extensive work-up when faced with a patient presenting with cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
Grosso et al. (2023) conducted a case report in Takotsubo Cardiomyopathy and Acute COVID-19 Pneumonia (n=1). Conservative medical management was evaluated on Clinical recovery and cardiac function. A 72-year-old female presenting with cardiogenic shock due to Takotsubo cardiomyopathy associated with acute COVID-19 pneumonia achieved complete clinical recovery with conservative management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: